These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8719029)

  • 21. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
    Rogóz Z; Dziedzicka-Wasylewska M; Daniel WA; Wójcikowski J; Dudek D; Wróbel A; Zieba A
    Pol J Pharmacol; 2004; 56(6):735-42. PubMed ID: 15662086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
    Gurevich EV; Joyce JN
    Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.
    Lawrence KM; Katona CL; Abou-Saleh MT; Robertson MM; Nairac BL; Edwards DR; Lock T; Burns RA; Harrison DA; Horton RW
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):261-4. PubMed ID: 7862905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3H-imipramine platelet binding sites in unipolar depression.
    Baron M; Barkai A; Gruen R; Kowalik S; Quitkin F
    Biol Psychiatry; 1983 Dec; 18(12):1403-9. PubMed ID: 6661469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of membrane protein concentration on binding of 3H-imipramine in human platelets.
    Barkai AI; Kowalik S; Baron M
    Biol Psychiatry; 1985 Feb; 20(2):215-9. PubMed ID: 3971002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
    Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circadian variation in platelet imipramine binding during the day in healthy subjects.
    Ellis PM; Beeston R; Cooke RR; Mellsop G
    Pharmacopsychiatry; 1991 May; 24(3):76-80. PubMed ID: 1891484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].
    Zarifian E; Sechter D; Bouchami F; Cuche H; Olie JP; Susini JR; Loo H; Briley M; Raisman R; Langer SZ
    Nouv Presse Med; 1982 Apr; 11(18):1385-7. PubMed ID: 7079155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between response to fluoxetine, plasma drug levels, imipramine binding to platelet membranes and whole-blood 5-HT.
    Tyrer SP; Marshall EF; Griffiths HW
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):797-805. PubMed ID: 1963498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet imipramine binding in autistic subjects.
    Anderson GM; Minderaa RB; van Benthem PP; Volkmar FR; Cohen DJ
    Psychiatry Res; 1984 Feb; 11(2):133-41. PubMed ID: 6584936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic effects of desmethylimipramine treatment on platelet serotonin uptake in depressed patients: a comparison with imipramine.
    Rausch JL; Moeller FG
    Psychiatry Res; 1991 Mar; 36(3):299-305. PubMed ID: 2062971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers.
    Raisman R; Sechter D; Briley MS; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1981; 75(4):368-71. PubMed ID: 6803282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid changes in 3H-imipramine platelet binding after chronic treatment with amineptine, a selective dopamine uptake blocker, in major depressed patients.
    Gronier B; Jeanningros R
    Fundam Clin Pharmacol; 1992; 6(2):89-95. PubMed ID: 1607147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet 3H-imipramine binding and steroid hormones serum concentrations during the menstrual cycle.
    Poirier MF; Benkelfat C; Galzin AM; Langer SZ
    Psychopharmacology (Berl); 1986; 88(1):86-9. PubMed ID: 3080779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of 3H-imipramine binding by plasma from depressed and normal subjects.
    Barkai AI; Baron M; Kowalik S; Cooper TB
    Psychiatry Res; 1986 Apr; 17(4):261-7. PubMed ID: 3714909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic imipramine treatment on subclasses of platelet 3H-imipramine binding sites and plasma cortisol.
    DeMet EM; Chicz-DeMet A; Bell KM; Reist C; Gerner RH
    Psychiatry Res; 1990 Dec; 34(3):303-13. PubMed ID: 1963693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased platelet 3H-imipramine binding and monoamine oxidase B activity in Alzheimer's disease.
    Bonuccelli U; Piccini P; Marazziti D; Cassano GB; Muratorio A
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):139-47. PubMed ID: 2222781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine.
    Berlanga C; Ortega-Soto HA; Ontiveros M; Senties H
    Psychiatry Res; 1992 Dec; 44(3):257-62. PubMed ID: 1289923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.